Latest Breaking News On - New technology add on payments - Page 1 : vimarsana.com

CMS Proposes Important Enhancements to the New Technology Add-on Payment Program in the FY 2025 IPPS Proposed Rulemaking | Foley Hoag LLP

On April 10, 2024, the Centers for Medicare & Medicaid Services (CMS) published the fiscal year (FY) 2025 Medicare Hospital Inpatient Prospective Payment Systems (IPPS) Proposed Rule,.

Compliance Considerations in High-Tech Healthcare | Gardner Law

Cutting-edge technology is desirable to consumers for its ability to deliver innovative solutions, improved efficiency, enhanced user experiences, and the promise of staying ahead in an.

Accessing Cell and Gene Therapies: Insights on Coverage, Reimbursement and Emerging Models | Manatt, Phelps & Phillips, LLP

Editor’s Note: In a new white paper, summarized below, Manatt Health discusses emerging reimbursement models for cell and gene therapies. The paper provides an overview of current.

TRICARE Coverage and Reimbursement of Certain Services Resulting From Temporary Program Changes in Response to the COVID-19 Pandemic

Document Number: "Docket ID: DoD -2020- HA-0040; and DoD -2020- HA-0050". Effective July 1, 2022 the interim final rules amending 32 CFR part 199, which were published at 85 FR 27921, May 12, 2020, and 85 FR 54914, September 3, 2020, are adopted as final with changes, except for the note to paragraph 199.4, published at 85 FR 54923, September 3, 2020, which remains interim.

Demy-Colton panel explains importance of U.S. market access planning ahead of Phase III trials | Hogan Lovells

Hogan Lovells has teamed up with Demy-Colton to host a special three-part webinar series focused on U.S. market access for life sciences firms, providing companies that are new to the.

Demy-Colton panel explains importance of U.S. market access planning ahead of Phase III trials

Hogan Lovells has teamed up with Demy-Colton to host a special three-part webinar series focused on U.S. market access for life sciences firms…

CMS Restructured The CAR-T DRG What It Means For Manufacturers 4 Strategies Forward

CMS Restructured The CAR-T DRG What It Means For Manufacturers 4 Strategies Forward